DCTH Stock Analysis: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$15.47
2.84 (22.49%)
▲
5d:
+28.49%
30d:
+18.09%
90d:
+37.39%
HOLD
MODERATE Confidence
Analysis Updated: Aug 6, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: DCTH is 14.2% above its trading range ($13.55). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: DCTH is 14.2% above its trading range ($13.55). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $15.47, which is considered extended relative to its 30-day fair value range of $12.11 to $13.55. From a valuation perspective, the stock is trading at a discount (Forward PE: -30.3) compared to its historical average (48.5). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, DCTH is in a strong uptrend. The price is approaching resistance at $15.62. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 22.5% recently.
Market Sentiment: DCTH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.55 (+39.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DCTH is in a strong uptrend. The price is approaching resistance at $15.62. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 22.5% recently.
Market Sentiment: DCTH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.55 (+39.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$12.11 -
$13.55
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price significantly overextended (+14.2% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+22.5%)
- BULLISH: Trading 39.3% below Wall St target ($21.55)
Trading Range Analysis
30-Day Trading Range
$12.11 -
$13.55
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$11.50
Resistance Level
$15.62
Current Trend
Strong Uptrend
Technical data as of
Aug 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-30.33
Wall Street Target
$21.55
(+39.3%)
Revenue Growth (YoY)
26.3%
Earnings Growth (YoY)
-66.7%
Profit Margin
0.6%
PE vs Historical
-30.3 vs 48.5
CHEAP
Share & Embed Analysis
Last updated: August 07, 2026 5:16 AM ET
Data refreshes hourly during market hours. Next update: 6:16 AM
Data refreshes hourly during market hours. Next update: 6:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 53 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 60 HOLD |
